Report Detail
Global Human Coagulation Factor VIII Market Research Report 2019
- RnM2922167 |
- 11 February, 2019 |
- Global |
- 108 Pages |
- QYResearch |
- Pharma & Healthcare
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A.
North America is the largest consumption market of Human Coagulation Factor VIII, with sales market share nearly 46%. And the production market share of Human Coagulation Factor VIII is 58%. The manufacturers of Human Coagulation Factor VIII in North America have big and medium scale.
The second place is Europe, following North America with the sales market share of 36% and the production market share over 28%. Many European players have plants in USA due to rich plasma source. So there are a large number of Human Coagulation Factor VIIIs for import from other regions.
Asia is another important market of Human Coagulation Factor VIII, enjoying 10% production market share and 11% sales market share. Especially in China, the sales and price of Factor VIII are controlled by country, and the price in China is different from other regions.
Main players are from USA and Europe, like Baxter, Bayer, and they have many plants in other regions. China also can supply Human Coagulation Factor VIII, but the products are mainly consumed in China.
Market competition is intense. Baxter, Bayer, CSL, Pfizer, Grifols, etc. are the leaders of the industry, and hold key technologies, with high-end customers, have been formed in the monopoly position in the industry. However, with further expanding market, there will be more manufactures in the future.
The global Human Coagulation Factor VIII market is valued at 7440 million US$ in 2018 is expected to reach 9420 million US$ by the end of 2025, growing at a CAGR of 3.0% during 2019-2025.
This report focuses on Human Coagulation Factor VIII volume and value at global level, regional level and company level. From a global perspective, this report represents overall Human Coagulation Factor VIII market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Shire (Baxter)
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Recombinant Factor VIII
Plasma-derived Factor VIII
Segment by Application
Hemophilia A
Spontanous / Trauma
Surgical
Other
Table of Contents
Executive Summary
1 Human Coagulation Factor VIII Market Overview
- 1.1 Product Overview and Scope of Human Coagulation Factor VIII
- 1.2 Human Coagulation Factor VIII Segment by Type
- 1.2.1 Global Human Coagulation Factor VIII Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Recombinant Factor VIII
- 1.2.3 Plasma-derived Factor VIII
- 1.3 Human Coagulation Factor VIII Segment by Application
- 1.3.1 Human Coagulation Factor VIII Consumption Comparison by Application (2014-2025)
- 1.3.2 Hemophilia A
- 1.3.3 Spontanous / Trauma
- 1.3.4 Surgical
- 1.3.5 Other
- 1.3 Global Human Coagulation Factor VIII Market by Region
- 1.3.1 Global Human Coagulation Factor VIII Market Size Region
- 1.3.2 North America Status and Prospect (2014-2025)
- 1.3.3 Europe Status and Prospect (2014-2025)
- 1.3.4 China Status and Prospect (2014-2025)
- 1.3.5 Japan Status and Prospect (2014-2025)
- 1.3.6 Southeast Asia Status and Prospect (2014-2025)
- 1.3.7 India Status and Prospect (2014-2025)
- 1.4 Global Human Coagulation Factor VIII Market Size
- 1.4.1 Global Human Coagulation Factor VIII Revenue (2014-2025)
- 1.4.2 Global Human Coagulation Factor VIII Production (2014-2025)
2 Global Human Coagulation Factor VIII Market Competition by Manufacturers
- 2.1 Global Human Coagulation Factor VIII Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Human Coagulation Factor VIII Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Human Coagulation Factor VIII Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Human Coagulation Factor VIII Production Sites, Area Served, Product Types
- 2.5 Human Coagulation Factor VIII Market Competitive Situation and Trends
- 2.5.1 Human Coagulation Factor VIII Market Concentration Rate
- 2.5.2 Human Coagulation Factor VIII Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Human Coagulation Factor VIII Production Market Share by Regions
- 3.1 Global Human Coagulation Factor VIII Production Market Share by Regions
- 3.2 Global Human Coagulation Factor VIII Revenue Market Share by Regions (2014-2019)
- 3.3 Global Human Coagulation Factor VIII Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Human Coagulation Factor VIII Production
- 3.4.1 North America Human Coagulation Factor VIII Production Growth Rate (2014-2019)
- 3.4.2 North America Human Coagulation Factor VIII Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Human Coagulation Factor VIII Production
- 3.5.1 Europe Human Coagulation Factor VIII Production Growth Rate (2014-2019)
- 3.5.2 Europe Human Coagulation Factor VIII Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Human Coagulation Factor VIII Production (2014-2019)
- 3.6.1 China Human Coagulation Factor VIII Production Growth Rate (2014-2019)
- 3.6.2 China Human Coagulation Factor VIII Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Human Coagulation Factor VIII Production (2014-2019)
- 3.7.1 Japan Human Coagulation Factor VIII Production Growth Rate (2014-2019)
- 3.7.2 Japan Human Coagulation Factor VIII Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Human Coagulation Factor VIII Consumption by Regions
- 4.1 Global Human Coagulation Factor VIII Consumption by Regions
- 4.2 North America Human Coagulation Factor VIII Consumption (2014-2019)
- 4.3 Europe Human Coagulation Factor VIII Consumption (2014-2019)
- 4.4 China Human Coagulation Factor VIII Consumption (2014-2019)
- 4.5 Japan Human Coagulation Factor VIII Consumption (2014-2019)
5 Global Human Coagulation Factor VIII Production, Revenue, Price Trend by Type
- 5.1 Global Human Coagulation Factor VIII Production Market Share by Type (2014-2019)
- 5.2 Global Human Coagulation Factor VIII Revenue Market Share by Type (2014-2019)
- 5.3 Global Human Coagulation Factor VIII Price by Type (2014-2019)
- 5.4 Global Human Coagulation Factor VIII Production Growth by Type (2014-2019)
6 Global Human Coagulation Factor VIII Market Analysis by Applications
- 6.1 Global Human Coagulation Factor VIII Consumption Market Share by Application (2014-2019)
- 6.2 Global Human Coagulation Factor VIII Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Human Coagulation Factor VIII Business
- 7.1 Shire (Baxter)
- 7.1.1 Shire (Baxter) Human Coagulation Factor VIII Production Sites and Area Served
- 7.1.2 Human Coagulation Factor VIII Product Introduction, Application and Specification
- 7.1.3 Shire (Baxter) Human Coagulation Factor VIII Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Bayer
- 7.2.1 Bayer Human Coagulation Factor VIII Production Sites and Area Served
- 7.2.2 Human Coagulation Factor VIII Product Introduction, Application and Specification
- 7.2.3 Bayer Human Coagulation Factor VIII Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 CSL
- 7.3.1 CSL Human Coagulation Factor VIII Production Sites and Area Served
- 7.3.2 Human Coagulation Factor VIII Product Introduction, Application and Specification
- 7.3.3 CSL Human Coagulation Factor VIII Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Pfizer
- 7.4.1 Pfizer Human Coagulation Factor VIII Production Sites and Area Served
- 7.4.2 Human Coagulation Factor VIII Product Introduction, Application and Specification
- 7.4.3 Pfizer Human Coagulation Factor VIII Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Grifols
- 7.5.1 Grifols Human Coagulation Factor VIII Production Sites and Area Served
- 7.5.2 Human Coagulation Factor VIII Product Introduction, Application and Specification
- 7.5.3 Grifols Human Coagulation Factor VIII Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Biogen
- 7.6.1 Biogen Human Coagulation Factor VIII Production Sites and Area Served
- 7.6.2 Human Coagulation Factor VIII Product Introduction, Application and Specification
- 7.6.3 Biogen Human Coagulation Factor VIII Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Octapharma
- 7.7.1 Octapharma Human Coagulation Factor VIII Production Sites and Area Served
- 7.7.2 Human Coagulation Factor VIII Product Introduction, Application and Specification
- 7.7.3 Octapharma Human Coagulation Factor VIII Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 NovoNordisk
- 7.8.1 NovoNordisk Human Coagulation Factor VIII Production Sites and Area Served
- 7.8.2 Human Coagulation Factor VIII Product Introduction, Application and Specification
- 7.8.3 NovoNordisk Human Coagulation Factor VIII Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 Greencross
- 7.9.1 Greencross Human Coagulation Factor VIII Production Sites and Area Served
- 7.9.2 Human Coagulation Factor VIII Product Introduction, Application and Specification
- 7.9.3 Greencross Human Coagulation Factor VIII Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
- 7.10 Kedrion
- 7.10.1 Kedrion Human Coagulation Factor VIII Production Sites and Area Served
- 7.10.2 Human Coagulation Factor VIII Product Introduction, Application and Specification
- 7.10.3 Kedrion Human Coagulation Factor VIII Production, Revenue, Price and Gross Margin (2014-2019)
- 7.10.4 Main Business and Markets Served
- 7.11 BPL
- 7.12 Hualan Bio
- 7.13 RAAS
8 Human Coagulation Factor VIII Manufacturing Cost Analysis
- 8.1 Human Coagulation Factor VIII Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Human Coagulation Factor VIII
- 8.4 Human Coagulation Factor VIII Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Human Coagulation Factor VIII Distributors List
- 9.3 Human Coagulation Factor VIII Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Human Coagulation Factor VIII Market Forecast
- 11.1 Global Human Coagulation Factor VIII Production, Revenue Forecast
- 11.1.1 Global Human Coagulation Factor VIII Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Human Coagulation Factor VIII Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Human Coagulation Factor VIII Price and Trend Forecast (2019-2025)
- 11.2 Global Human Coagulation Factor VIII Production Forecast by Regions (2019-2025)
- 11.2.1 North America Human Coagulation Factor VIII Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Human Coagulation Factor VIII Production, Revenue Forecast (2019-2025)
- 11.2.3 China Human Coagulation Factor VIII Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Human Coagulation Factor VIII Production, Revenue Forecast (2019-2025)
- 11.3 Global Human Coagulation Factor VIII Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Human Coagulation Factor VIII Consumption Forecast (2019-2025)
- 11.3.2 Europe Human Coagulation Factor VIII Consumption Forecast (2019-2025)
- 11.3.3 China Human Coagulation Factor VIII Consumption Forecast (2019-2025)
- 11.3.4 Japan Human Coagulation Factor VIII Consumption Forecast (2019-2025)
- 11.4 Global Human Coagulation Factor VIII Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Human Coagulation Factor VIII Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Human Coagulation Factor VIII . Industry analysis & Market Report on Human Coagulation Factor VIII is a syndicated market report, published as Global Human Coagulation Factor VIII Market Research Report 2019. It is complete Research Study and Industry Analysis of Human Coagulation Factor VIII market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
